Free Trial

Warby Parker (WRBY) Competitors

Warby Parker logo
$22.04 -0.42 (-1.87%)
Closing price 06/13/2025 03:59 PM Eastern
Extended Trading
$22.16 +0.11 (+0.52%)
As of 06/13/2025 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

WRBY vs. STVN, GKOS, NARI, IRTC, TMDX, BLCO, INSP, SLNO, PRCT, and NVST

Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Stevanato Group (STVN), Glaukos (GKOS), Inari Medical (NARI), iRhythm Technologies (IRTC), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), and Envista (NVST). These companies are all part of the "medical equipment" industry.

Warby Parker vs. Its Competitors

Warby Parker (NYSE:WRBY) and Stevanato Group (NYSE:STVN) are both mid-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings, risk and community ranking.

Stevanato Group has higher revenue and earnings than Warby Parker. Warby Parker is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Warby Parker$795.09M2.90-$63.20M-$0.12-183.68
Stevanato Group$1.12B6.30$157.62M$0.5145.88

In the previous week, Warby Parker had 4 more articles in the media than Stevanato Group. MarketBeat recorded 6 mentions for Warby Parker and 2 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.79 beat Warby Parker's score of 0.79 indicating that Stevanato Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Warby Parker
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Stevanato Group
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

93.2% of Warby Parker shares are held by institutional investors. 18.2% of Warby Parker shares are held by insiders. Comparatively, 0.7% of Stevanato Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Warby Parker received 24 more outperform votes than Stevanato Group when rated by MarketBeat users. However, 63.27% of users gave Stevanato Group an outperform vote while only 46.61% of users gave Warby Parker an outperform vote.

CompanyUnderperformOutperform
Warby ParkerOutperform Votes
55
46.61%
Underperform Votes
63
53.39%
Stevanato GroupOutperform Votes
31
63.27%
Underperform Votes
18
36.73%

Stevanato Group has a net margin of 10.47% compared to Warby Parker's net margin of -4.39%. Stevanato Group's return on equity of 9.86% beat Warby Parker's return on equity.

Company Net Margins Return on Equity Return on Assets
Warby Parker-4.39% -8.26% -4.37%
Stevanato Group 10.47%9.86%5.79%

Warby Parker presently has a consensus target price of $22.88, indicating a potential upside of 3.78%. Given Warby Parker's higher probable upside, equities analysts plainly believe Warby Parker is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Warby Parker
0 Sell rating(s)
7 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.61
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.86

Warby Parker has a beta of 2.1, indicating that its share price is 110% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500.

Summary

Stevanato Group beats Warby Parker on 12 of the 19 factors compared between the two stocks.

Get Warby Parker News Delivered to You Automatically

Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

WRBY vs. The Competition

MetricWarby ParkerOphthalmic goods IndustryStaples SectorNYSE Exchange
Market Cap$2.30B$10.40B$17.41B$19.68B
Dividend YieldN/A0.96%3.06%3.81%
P/E Ratio-81.6332.3216.3534.98
Price / Sales2.902.9443.5842.85
Price / CashN/A14.5316.3917.51
Price / Book7.162.596.084.78
Net Income-$63.20M$224.27M$737.47M$1.02B
7 Day Performance2.01%-2.23%7.56%0.82%
1 Month Performance26.45%2.81%5.12%1.74%
1 Year Performance35.97%-17.44%8.82%10.57%

Warby Parker Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
WRBY
Warby Parker
1.8483 of 5 stars
$22.04
-1.9%
$22.88
+3.8%
+36.5%$2.30B$795.09M-81.633,030Positive News
STVN
Stevanato Group
1.7271 of 5 stars
€22.01
-0.9%
N/A+27.9%$6.67B$1.12B46.834,650
GKOS
Glaukos
4.4155 of 5 stars
$94.89
+0.6%
$134.67
+41.9%
-14.0%$5.42B$404.52M-33.06780
NARI
Inari Medical
0.4738 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
IRTC
iRhythm Technologies
1.2639 of 5 stars
$140.65
+0.1%
$133.73
-4.9%
+55.0%$4.49B$618.59M-38.641,790News Coverage
Analyst Forecast
TMDX
TransMedics Group
1.2939 of 5 stars
$123.94
-2.5%
$126.70
+2.2%
-0.4%$4.19B$488.23M131.85210
BLCO
Bausch + Lomb
4.2827 of 5 stars
$11.46
-0.1%
$15.50
+35.3%
-16.8%$4.05B$4.83B-12.5912,500
INSP
Inspire Medical Systems
4.8022 of 5 stars
$133.66
-3.3%
$211.91
+58.5%
-24.1%$3.94B$840.11M77.26760Positive News
SLNO
Soleno Therapeutics
4.7471 of 5 stars
$75.66
+3.1%
$106.78
+41.1%
+75.8%$3.81BN/A-22.7930Positive News
Analyst Revision
PRCT
PROCEPT BioRobotics
1.9192 of 5 stars
$57.94
-0.1%
$90.00
+55.3%
-4.5%$3.21B$249.12M-29.71430News Coverage
Positive News
Insider Trade
NVST
Envista
3.3964 of 5 stars
$18.09
-1.0%
$20.23
+11.8%
+3.5%$3.07B$2.50B-2.7912,700Positive News

Related Companies and Tools


This page (NYSE:WRBY) was last updated on 6/14/2025 by MarketBeat.com Staff
From Our Partners